Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas

Background: Lower-grade glioma (LGG) is the most common histology identified in gliomas, a heterogeneous tumor that may develop into high-grade malignant glioma that seriously shortens patient survival time. Recent studies reported that glutamatergic synapses might play an essential role in the prog...

Full description

Bibliographic Details
Main Authors:	Liguo Ye, Yang Xu, Ping Hu, Long Wang, Ji’an Yang, Fan’en Yuan, Yixuan Wang, Chunyu Zhang, Daofeng Tian, Qianxue Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Molecular Neuroscience
Subjects:	lower-grade glioma glutamatergic synapses risk signature tumor immune microenvironment immunity profile
Online Access:	https://www.frontiersin.org/articles/10.3389/fnmol.2021.720899/full

Similar Items

Prognostic value of γ‐aminobutyric acidergic synapse-associated signature for lower-grade gliomas
by: Hongxiang Jiang, et al.
Published: (2022-11-01)

The Effects of Doxapram Blocking the Response of Gram-Negative Bacterial Toxin (LPS) at Glutamatergic Synapses
by: Kaitlyn E. Brock, et al.
Published: (2023-07-01)

Development and Verification of the Amino Metabolism-Related and Immune-Associated Prognosis Signature in Gliomas
by: Yang Xu, et al.
Published: (2021-11-01)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
by: Hongbo Zhang, et al.
Published: (2020-12-01)

Comparative profiling of immune genes improves the prognoses of lower grade gliomas
by: Zhiliang Wang, et al.
Published: (2022-04-01)

A Novel Six Autophagy-Related Genes Signature Associated With Outcomes and Immune Microenvironment in Lower-Grade Glioma
by: Tao Lin, et al.
Published: (2021-10-01)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
by: Xiangyang Deng, et al.
Published: (2019-11-01)

Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics
by: Zihao Zhang, et al.
Published: (2022-10-01)

Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma
by: Junsheng Zhao, et al.
Published: (2021-11-01)

Altered Spontaneous Glutamatergic and GABAergic Activity in the Peritumoral Cortex of Low-Grade Gliomas Presenting With History of Seizures
by: Soumil Dey, et al.
Published: (2021-06-01)

Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas
by: Rui Tao, et al.
Published: (2023-07-01)

A Panel of Synapse-Related Genes as a Biomarker for Gliomas
by: Xiangwen Ji, et al.
Published: (2020-08-01)

Morphological changes of glutamatergic synapses in animal models of Parkinson’s disease
by: Rosa M Villalba, et al.
Published: (2015-09-01)

Identification and Validation of a Seizure-Free-Related Gene Signature for Predicting Poor Prognosis in Lower-Grade Gliomas
by: Li J, et al.
Published: (2021-10-01)

Identification and validation of a 17-gene signature to improve the survival prediction of gliomas
by: Shiao Tong, et al.
Published: (2022-09-01)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
by: Mingwei Zhang, et al.
Published: (2020-04-01)

Glutamatergic Synapse Dysfunction in Drosophila Neuromuscular Junctions Can Be Rescued by Proteostasis Modulation
by: Anushka Chakravorty, et al.
Published: (2022-07-01)

Prediction of Survival Outcome in Lower-Grade Glioma Using a Prognostic Signature with 33 Immune-Related Gene Pairs
by: Chen S, et al.
Published: (2021-11-01)

The integrative analysis based on super-enhancer related genes for predicting different subtypes and prognosis of patient with lower-grade glioma
by: Yungang Hu, et al.
Published: (2023-04-01)

Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma
by: Yudong Cao, et al.
Published: (2022-08-01)

Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma
by: Huihan Yu, et al.
Published: (2022-08-01)

Association between TRP channels and glutamatergic synapse gene polymorphisms and migraine and the comorbidities anxiety and depression in a Chinese population
by: Mingxue Wang, et al.
Published: (2023-05-01)

Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
by: Wen-Jing Zeng, et al.
Published: (2018-05-01)

Identification of Immunological Characteristics and Immune Subtypes Based on Single-Sample Gene Set Enrichment Analysis Algorithm in Lower-Grade Glioma
by: Yunyang Zhu, et al.
Published: (2022-05-01)

A Bioinformatics-Based Analysis of an Anoikis-Related Gene Signature Predicts the Prognosis of Patients with Low-Grade Gliomas
by: Songyun Zhao, et al.
Published: (2022-10-01)

Proteomics and weighted gene correlated network analysis reveal glutamatergic synapse signaling in diazepam treatment of alcohol withdrawal
by: Wan Kong, et al.
Published: (2023-01-01)

Collagen XIX is required for pheromone recognition and glutamatergic synapse formation in mouse accessory olfactory bulb
by: Chase Amos, et al.
Published: (2023-04-01)

Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy
by: Ganglei Li, et al.
Published: (2021-11-01)

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma
by: Qian-Rong Huang, et al.
Published: (2022-06-01)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
by: Jiayang Cai, et al.
Published: (2022-10-01)

Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma
by: Jie Wang, et al.
Published: (2022-09-01)

Transcription Factor Signatures May Predict the Prognosis and Status of the Immune Microenvironment of Primary Lower-Grade Gliomas
by: Liu P, et al.
Published: (2021-11-01)

Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes
by: Junsheng Li, et al.
Published: (2022-10-01)

Heterogeneity in clinical prognosis, immune infiltration and molecular characteristics of three glycolytic subtypes in lower-grade gliomas
by: Shenglian Wu, et al.
Published: (2023-05-01)

Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
by: Qiang Zhang, et al.
Published: (2021-07-01)

Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development
by: Liguo Ye, et al.
Published: (2021-08-01)

Comprehensive analyses of m1A regulator-mediated modification patterns determining prognosis in lower-grade glioma (running title: m1A in LGG)
by: Kunjian Lei, et al.
Published: (2024-03-01)

Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas
by: Yirui Kuang, et al.
Published: (2023-04-01)

Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs
by: Jing Wen, et al.
Published: (2020-11-01)

ZNF480 influences the prognosis, pathogenesis, and immune microenvironment in patients with lower-grade glioma
by: Qingyun Zhu, et al.
Published: (2023-07-01)